tiprankstipranks
Trending News
More News >
Daré Bioscience Inc (DARE)
NASDAQ:DARE
US Market

Daré Bioscience (DARE) Income Statement

Compare
1,879 Followers

Daré Bioscience Income Statement

Last quarter (Q3 2025), Daré Bioscience's total revenue was $2.26K, a decrease of -94.57% from the same quarter last year. In Q3, Daré Bioscience's net income was $-3.56M. See Daré Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.78K$ 2.81M$ 10.00M$ 0.00$ 0.00
Gross Profit
$ -14.30M$ -18.83M$ -20.14M$ -100.00K$ -83.33K
Operating Expenses
$ 9.16M$ 12.11M$ 11.24M$ 38.97M$ 27.32M
Depreciation and Amortization
$ 42.33K$ 38.36K$ 24.20K$ 26.41K$ 43.23K
EBITDA
$ -23.41M$ -30.70M$ -31.36M$ -39.04M$ -27.36M
Operating Income
$ -23.45M$ -30.94M$ -31.39M$ -39.07M$ -27.40M
Other Income/Expenses
$ 19.40M$ 778.49K$ 437.75K$ 372.41K$ 1.51K
Pretax Income
$ -4.05M$ -30.16M$ -30.95M$ -38.70M$ -27.40M
Net Income
$ -4.05M$ -30.16M$ -30.95M$ -38.70M$ -27.40M
Per Share Metrics
Basic EPS
$ -0.48$ -4.15$ -4.39$ -7.52$ -10.93
Diluted EPS
$ -0.48$ -4.15$ -4.39$ -7.52$ -10.93
Weighted Average Shares Outstanding
8.50M 7.28M 7.05M 5.10M 2.51M
Weighted Average Shares Outstanding (Diluted)
8.50M 7.28M 7.05M 5.10M 2.51M
Currency in USD

Daré Bioscience Earnings and Revenue History